Respiratory syncytial virus non-structural protein 1 facilitates virus replication through miR-29a-mediated inhibition of interferon-α receptor
- PMID: 27569280
- DOI: 10.1016/j.bbrc.2016.08.142
Respiratory syncytial virus non-structural protein 1 facilitates virus replication through miR-29a-mediated inhibition of interferon-α receptor
Abstract
Human respiratory syncytial virus (RSV) non-structural protein 1 (NS1) has recently been suggested to inhibit type-I interferon (IFN)-dependent immune responses during RSV infection. However, the precise function of RSV NS1 protein in reducing the antiviral effects of IFNs against RSV is poorly understood. The roles of cellular miRNAs in the defence against RSV infection are not well characterized. In this study, qRT-PCR analysis revealed that miR-29a expression was upregulated in the recombinant wild-type RSV (rRSV-WT) group compared with the control group, but no changes were observed in the recombinant RSV mutant lacking NS1 (rRSV-ΔNS1) group. Using dual-luciferase reporter assay, we demonstrated that miR-29a could directly target IFNAR1 3'-UTR and downregulate IFNAR1 expression. In addition, RSV NS1 suppressed IFNAR1 expression at both RNA level and protein level in human lung adenocarcinoma cell line A549. RSV plaque assays showed that the number of RSV plaques in miR-29a mimics group was significantly higher than that in miR-29a inhibitor group or miRNA scramble control group. HA-NS1 overexpression increased the numbers of RSV plaque, but the promotive effect on virus replication was attenuated in cells transfected with miR-29a inhibitors. These results suggest that miR-29a, upregulated during RSV infection, is a negative regulator of IFNAR1 and is critical for RSV NS1-induced virus replication.
Keywords: Interferon-α receptor; Non-structural protein 1; Replication; Respiratory syncytial virus; miR-29a.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.PLoS Pathog. 2019 Oct 17;15(10):e1007984. doi: 10.1371/journal.ppat.1007984. eCollection 2019 Oct. PLoS Pathog. 2019. PMID: 31622448 Free PMC article. Review.
-
Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β.J Gen Virol. 2015 Nov;96(11):3179-3191. doi: 10.1099/jgv.0.000261. J Gen Virol. 2015. PMID: 26253191 Free PMC article.
-
An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.J Virol. 2022 Oct 12;96(19):e0129722. doi: 10.1128/jvi.01297-22. Epub 2022 Sep 14. J Virol. 2022. PMID: 36102648 Free PMC article. Review.
-
Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.J Virol. 2016 Jun 24;90(14):6453-6463. doi: 10.1128/JVI.00423-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27147743 Free PMC article.
-
Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway.Virol J. 2020 Nov 25;17(1):187. doi: 10.1186/s12985-020-01451-6. Virol J. 2020. PMID: 33239033 Free PMC article.
Cited by
-
Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2020587118. doi: 10.1073/pnas.2020587118. Proc Natl Acad Sci U S A. 2021. PMID: 33649232 Free PMC article.
-
Research progress on miRNAs function in the interaction between human infectious viruses and hosts: A review.Biomol Biomed. 2024 Oct 17;24(6):1452-1462. doi: 10.17305/bb.2024.10821. Biomol Biomed. 2024. PMID: 39101759 Free PMC article. Review.
-
Interferon and immunity: the role of microRNA in viral evasion strategies.Front Immunol. 2025 May 9;16:1567459. doi: 10.3389/fimmu.2025.1567459. eCollection 2025. Front Immunol. 2025. PMID: 40416980 Free PMC article. Review.
-
Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.PLoS Pathog. 2019 Oct 17;15(10):e1007984. doi: 10.1371/journal.ppat.1007984. eCollection 2019 Oct. PLoS Pathog. 2019. PMID: 31622448 Free PMC article. Review.
-
The Impact of Type 1 Interferons on Alveolar Macrophage Tolerance and Implications for Host Susceptibility to Secondary Bacterial Pneumonia.Front Immunol. 2020 Mar 20;11:495. doi: 10.3389/fimmu.2020.00495. eCollection 2020. Front Immunol. 2020. PMID: 32265937 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials